HLA Class I (A and B) Allele Polymorphism in a Moroccan Population Infected with Hepatitis C Virus

Safa Machraoui1,2,3, Abdelmalek Hakmaoui1, Khaoula Errafii3

  • 1Laboratory of Immunology and Human Leukocyte Antigen, Center of Clinical Research, Mohammed VI University Hospital, Marrakech 40080, Morocco.

PubMed

Insights

Human leukocyte antigen (HLA) gene variations influence Hepatitis C virus (HCV) infection outcomes. Specific HLA-A and HLA-B alleles show associations with HCV susceptibility and clearance, offering insights into disease progression.

Area of Science:

  • Immunogenetics
  • Virology
  • Hepatology

Background:

  • Hepatitis C virus (HCV) infection poses a global health challenge, with disease course influenced by viral factors and host immune responses.
  • Host immunogenetics, particularly human leukocyte antigens (HLAs), play a crucial role in determining HCV infection outcomes, varying across populations.
  • Understanding the association between specific HLA alleles and HCV infection is vital for disease susceptibility and clearance insights.

Purpose of the Study:

  • To investigate the relationship between HLA-A and HLA-B allele polymorphism and the clinical outcome of Hepatitis C virus infection.
  • To elucidate the impact of immunogenetic factors on HCV susceptibility and viral clearance.
  • To enhance understanding of disease pathogenesis and identify potential targeted interventions.

Main Methods:

  • A cross-sectional, comparative study involving 40 HCV patients and 100 healthy controls from southern Morocco.
  • High-resolution PCR-SSO method used for HLA class I allele typing.
  • Statistical analysis to compare allele prevalence between patient and control groups.

Main Results:

  • Significant differences in the prevalence of specific HLA class I alleles were observed between HCV-infected individuals and healthy controls.
  • HLA-A*02:01 was less prevalent in chronic HCV infection, suggesting a potential protective effect (p = 0.002).
  • Increased prevalence of HLA-A*68:02, A*66:01, B*15:03, B*41:02, B*44:03, and B*50:01 alleles in patients indicated potential predisposing factors.

Conclusions:

  • The study supports the association of specific immunogenetic markers (HLA alleles) with HCV infection.
  • These HLA alleles may play a role in determining clinical manifestations, genotype distribution, and overall outcomes of HCV infection.
  • Further analysis of these alleles can deepen the understanding of HCV pathogenesis and inform targeted therapeutic strategies.